Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)

Author:

Lichtlen Paul R.,Hugenholtz Paul G.,Rafflenbeul Wolfgang,Hecker Hartmut,Jost Stefan,Nikutta Peter,Deckers Jaap W.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Reference52 articles.

1. Henry PD, Bentley K. Suppression of atherosclerosis in cholesterol-fed rabbits treated with nifedipine.J Clin Invest 1981;68:1366–1369.

2. Nayler WG, Dillon JS, Panagiotopoulos S, Sturrock WJ, Dihydropyridines and the ischaemic, myocardium. In: Lichtlen PR ed.6th Adalat Symposium. New Therapy of Ischemic Heart Disease and Hypertension. Amsterdam: Excerpta Medica, 1986:486–397.

3. Watanabe N, Ischikawa Y, Mukodani J, et al. Nifedipine suppresses arteriosclerosis in cholesterol-fed rabbits but not in WHHL-rabbits.Circulation 1985;77:II281.

4. Willis AL, Nagel B, Churchill V, et al. Antiatherosclerotic effects of nicardipine, and nifedipine in cholesterol-fed rabbits.Arteriosclerosis 1985;5:250–255.

5. Ginsburg R, Davis K, Bristow MR, et al. Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary artery of cholesterol-fed rabbits.Lab Invest 1983;49:154–158.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3